2021 KUMC Virtual Multidisciplinary Oncology Review
Playback speed
10 seconds
KUMC Updated Data on mCRPC: Cabazitaxel vs. Abiraterone/Enzalutamide, Lu-177 vs. Cabazitaxel, Olaparib vs. Enzalutamide/Abiraterone, Rucaparib for BRCA Alterations
27 views
May 17, 2021
Comments 0
Login to view comments.
Click here to Login
Videos